ICMR invites bids from pharma firms for development of vaccine against Monkeypox - Video
Overview
The National Institute of Virology (NIV) in Pune under ICMR has isolated the monkeypox virus from the clinical specimen of a patient which can pave the way for the development of diagnostic kits and vaccines against the disease, the apex health research body said on Wednesday.
With India isolating the virus, the Indian Council of Medical Research (ICMR) also invited expression of interest (EoI), proposing to hand over the strain to interested Indian vaccine manufacturers, pharma companies and in-vitro diagnostic industry partners for the development of indigenous vaccines against monkeypox and diagnostic kits for detection of the disease.
For more details, check out the full story on the link below:
ICMR Invites Bids From Pharma Companies For Development Of Monkeypox Vaccine
Speakers
